Researchers at Boston Children’s Hospital are evaluating access to gluten-free food prior to and during the COVID-19 pandemic. We invite anyone with celiac disease following a gluten-free diet to complete this 3-5 minute survey.
Continue ReadingJoin the Schär team for their first ever 3-part School Nutrition Webinar Series on managing celiac disease and other dietary restrictions in learning environments! Register for free for all 3 days and be eligible for CEUs and a Schär giveaway!
Continue ReadingPeriodically, the FDA hosts workshops to help researchers understand exactly what the FDA will be looking for (aka “endpoints”) when evaluating the efficacy of a proposed drug.
Continue ReadingResearchers at MassGeneral Hospital for Children have found substantial gut microbiome changes in the intestines of at-risk infants before celiac disease onset.
Continue ReadingZED1227, an experimental drug was found to be able to prevent intestinal damage in a preliminary trial of 163 adults with celiac disease.
Continue ReadingThe Celiac Disease Foundation is pleased to invite you to the FDA’s GREAT VI, Gastroenterology Regulatory Endpoints and the Advancement of Therapeutics Workshop on Celiac Disease, on Thursday, July 22, 2021 at 9AM Eastern.
Continue Reading68 percent of survey participants indicated that celiac disease had a major/moderate impact on their dating life.
Continue ReadingThe overall prevalence of celiac disease was found to be 1.6% - a much greater percentage than the 1% that researchers have been approximating for years.
Continue ReadingThe Celiac Disease Foundation is proud to be selected as an Official Charity Partner in the 2021 TCS New York City Marathon and open the application process for our 2021 NYC Marathon Team Gluten-Free team! We are seeking five runners who are passionate and seriously committed to training, running, and fundraising to accelerate celiac disease research. Please complete the application to join our 2021 team by June 23, 2021, 6pm PST. Ready, set, go!
Continue ReadingCabinet Health, a verified gluten-free OTC medicine company, announced their partnership with the Celiac Disease Foundation in order to better support the needs of the celiac community.
Continue ReadingLast month, the Celiac Disease Foundation had the privilege of sponsoring the 2024 International Celiac Disease Symposium in Sheffield, UK. As the first patient advocate invited to chair and present on a scientific panel, CEO Marilyn Geller co-chaired the End Points in Clinical Trials session with Dr. Francisco Leon, CEO...